Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Wedel

Showing results (91-100 of 161) with videos related to

Pageof 17
Sort By:
Acta Medica Scandinavica|January 1, 1977
Prediction of cardiovascular deaths and non-fatal reinfarctions after myocardial infarctionA Vedin, L Wilhelmsen, H Wedel, et al.
Journal of the American College of Cardiology|October 5, 2001
Metoprolol controlled release/extended release in patients with severe heart failure: analysis of the experience in the MERIT-HF studyS Goldstein, B Fagerberg, Hjalmarson A, et al.
The American Journal of Cardiology|June 25, 1984
Göteborg Metoprolol Trial: toleranceJ Herlitz, K Pennert, H Wedel, et al.
BMJ (Clinical Research Ed.)|March 10, 1990
Social influences and cardiovascular risk factors as determinants of plasma fibrinogen concentration in a general population sample of middle aged menA Rosengren, L Wilhelmsen, L Welin, et al.
European Heart Journal|April 1, 1985
Recurrent myocardial infarction. 2. Possibilities of predictionG Ulvenstam, A Aberg, K Pennert, et al.
Journal of Hypertension|April 1, 1985
Predictors of cardiovascular morbidity in treated hypertension: results from the primary preventive trial in Göteborg, SwedenO Samuelsson, L Wilhelmsen, D Elmfeldt, et al.
The New England Journal of Medicine|January 30, 1997
Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. Scandinavian Simvastatin Survival Study GroupM Johannesson, B Jönsson, J Kjekshus, et al.
Journal of Hypertension|June 1, 1990
The J-shaped relationship between coronary heart disease and achieved blood pressure level in treated hypertension: further analyses of 12 years of follow-up of treated hypertensives in the Primary Prevention Trial in Gothenburg, SwedenO G Samuelsson, L W Wilhelmsen, K M Pennert, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 27, 2012
Feasibility of the FINDRISC questionnaire to identify individuals with impaired glucose tolerance in Swedish primary care. A cross-sectional population-based studyM I Hellgren, M Petzold, C Björkelund, et al.
Journal of Hypertension|May 2, 2001
Risk assessment and treatment benefit in intensively treated hypertensive patients of the hypertension Optimal Treatment (HOT) studyA Zanchetti, L Hansson, J Ménard, et al.
Pageof 17

Showing results (91-100 of 161) with videos related to

Sort By:
Pageof 17
Acta Medica Scandinavica|January 1, 1977
Prediction of cardiovascular deaths and non-fatal reinfarctions after myocardial infarctionA Vedin, L Wilhelmsen, H Wedel, et al.
Journal of the American College of Cardiology|October 5, 2001
Metoprolol controlled release/extended release in patients with severe heart failure: analysis of the experience in the MERIT-HF studyS Goldstein, B Fagerberg, Hjalmarson A, et al.
The American Journal of Cardiology|June 25, 1984
Göteborg Metoprolol Trial: toleranceJ Herlitz, K Pennert, H Wedel, et al.
BMJ (Clinical Research Ed.)|March 10, 1990
Social influences and cardiovascular risk factors as determinants of plasma fibrinogen concentration in a general population sample of middle aged menA Rosengren, L Wilhelmsen, L Welin, et al.
European Heart Journal|April 1, 1985
Recurrent myocardial infarction. 2. Possibilities of predictionG Ulvenstam, A Aberg, K Pennert, et al.
Journal of Hypertension|April 1, 1985
Predictors of cardiovascular morbidity in treated hypertension: results from the primary preventive trial in Göteborg, SwedenO Samuelsson, L Wilhelmsen, D Elmfeldt, et al.
The New England Journal of Medicine|January 30, 1997
Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. Scandinavian Simvastatin Survival Study GroupM Johannesson, B Jönsson, J Kjekshus, et al.
Journal of Hypertension|June 1, 1990
The J-shaped relationship between coronary heart disease and achieved blood pressure level in treated hypertension: further analyses of 12 years of follow-up of treated hypertensives in the Primary Prevention Trial in Gothenburg, SwedenO G Samuelsson, L W Wilhelmsen, K M Pennert, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 27, 2012
Feasibility of the FINDRISC questionnaire to identify individuals with impaired glucose tolerance in Swedish primary care. A cross-sectional population-based studyM I Hellgren, M Petzold, C Björkelund, et al.
Journal of Hypertension|May 2, 2001
Risk assessment and treatment benefit in intensively treated hypertensive patients of the hypertension Optimal Treatment (HOT) studyA Zanchetti, L Hansson, J Ménard, et al.
Pageof 17